Skip to main content

Patient Support Line 1-800-282-7630, Monday – Friday: 9 AM – 5 PM ET

Here are some available KISQALI Patient Resources that can help you learn more about treatment with KISQALI. Save these materials to your mobile device or tablet, or print them out so you can keep this useful information close at hand.

KISQALI Patient Brochure

Patient Brochure (English)

Find answers to many of your questions about KISQALI, HR+, HER2- metastatic breast cancer.
Download
Spanish KISQALI Patient Brochure

Patient Brochure (Spanish)

Find answers to many of your questions about KISQALI, HR+, HER2- metastatic breast cancer.
Download
KISQALI Day-to-Day Patient Resources

Day-to-Day Patient Resources

Learn about independent support organizations that can offer services to complement treatment plans and care such as transportation, lodging, healthy meals, home cleaning, and more.
Download
KISQALI Doctor Discussion Guide

Doctor Discussion Guide

Make the most of your time with your doctor. Get tips on preparing for appointments, processing information, and questions to ask about KISQALI.
Download

Important Safety Information

What is the most important information I should know about KISQALI ?

KISQALI may cause serious side effects, including:

Lung problems. KISQALI may cause severe or life-threatening inflammation of the lungs during treatment that may lead to death. Tell your health care provider right away if you have any new or...

Indications

KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (metastatic), in combination with:

  • an aromatase inhibitor as the first endocrine-based therapy; or...
Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USE